Steve Schram — investor profile photo

Steve Schram

VP Business Development

📍 United States🔄 Updated November 2026💼 1 investments📅 2 years investing🗓 Last invested Jan 2024
Angel investor🌍 United States
1
Total investments
0
Early stage
0
Mid stage
1
Late stage
2y
Years active

Portfolio

1 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor and Corporate Advisor
Jan 2024
Phoreus Biotechnology, Inc. is the provider of a proprietary technology platform with the capacity to revolutionize global One Health. Our Branched Amphipathic Peptide Capsules™ (BAPC™) offer substantially increased efficacy in the creation and delivery of novel vaccines, cancer therapies, alternative antibiotics and biopesticides for improved human, animal, plant and environmental health around the world.
Experience · 1 entries
All (1)
Investments (1)
2024
Investor and Corporate Advisor
Jan 2024
Phoreus Biotechnology, Inc. is the provider of a proprietary technology platform with the capacity to revolutionize global One Health. Our Branched Amphipathic Peptide Capsules™ (BAPC™) offer substantially increased efficacy in the creation and delivery of novel vaccines, cancer therapies, alternative antibiotics and biopesticides for improved human, animal, plant and environmental health around the world.
Investor lists
Lists that match Steve's portfolio